During the study, researchers found that the infants of resulting from the pregnancies of people with pregestational type 2 diabetes had a substantially higher frequency of major congenital malformations including cardiac malformations than infants in the general population
Electrolyte+ Hydration + energy support
[15] However, the combination also carries risks
During the initial period of using any new transdermal medication, patients may experience local skin reactions such as mild redness, itching, or irritation at the application site
As there was clear evidence of clinically significant weight loss from the Phase III trials, tirzepatide has been planned to be evaluated as an anti-obesity drug in non-diabetic (SURMOUNT 1 trial), and diabetic (SURMOUNT 2 trial) populations, and on those who are already on intensive lifestyle programmes (SURMOUNT 3 trial)
These QUS approaches have limited depth of penetration and often yield inaccurate results, or are unable to obtain measurements in severely obese individuals